Furthermore, in the sub-group analysis, expression of GLUT-1 was associated with shorter OS in pancreatic cancer, gastric cancer and Asian populations, while colorectal cancer patients showed a positive relation to GLUT-1. Here, SLC2A1 is linked to pancreatic neoplasm.